Nanobiotix SA (NANO) Stock Price & News

Nanobiotix is a biotechnology company that uses nanomedicine to develop new radiotherapy techniques for cancer patients. The company is headquartered in Paris, with additional corporate offices in New York and Massachusetts. Wikipedia

About Nanobiotix SA

CEOLaurent Levy

Employees98

Founded2003

Headquarters-

Sector-

Websitenanobiotix.com

All values in EUR	Sep. 2025	Des. 2025	Mrt. 2026	Jun. 2026
Revenue	2,98 m	2,98 m	2,78 m	2,78 m
Cost of goods sold	-	-	-	-
Cost of revenue	-	-	-	-
Research and development expenses	4,29 m	4,29 m	6,36 m	6,36 m
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	4,53 m	4,53 m	5,38 m	5,38 m
Operating expense	8,83 m	8,83 m	11,74 m	11,74 m
Total operating expenses	8,83 m	8,83 m	11,74 m	11,74 m
Operating income	-5,85 m	-5,85 m	-8,96 m	-8,96 m
Other non operating income	-8,50 k	-8,50 k	-1,00 k	-1,00 k
EBT including unusual items	-9,29 m	-9,29 m	-17,14 m	-17,14 m
EBT excluding unusual items	-8,57 m	-8,57 m	-16,56 m	-16,56 m
Income tax expense	-1,50 k	-1,50 k	8,00 k	8,00 k
Effective tax rate	0,02%	0,02%	-0,05%	-0,05%
Other operating expenses	-	-	-	-
Net income	-9,29 m	-9,29 m	-17,14 m	-17,14 m
Net profit margin	-311,97%	-311,97%	-617,69%	-617,69%
Earnings per share	-	-	-	-
Interest and investment income	193,50 k	193,50 k	338,50 k	338,50 k
Interest expense	-3,08 m	-3,08 m	-7,28 m	-7,28 m
Net interest expenses	-2,88 m	-2,88 m	-6,94 m	-6,94 m
Depreciation and amortization charges	-	-	-	-
EBITDA	-5,79 m	-5,79 m	-8,84 m	-8,84 m
Gain or loss from assets sale	76,50 k	76,50 k	-	-

Ask anything